Literature DB >> 31362858

Using Protozoan Surface Proteins for Effective Oral Vaccination.

Lucía Lara Rupil1, Marianela Del Carmen Serradell2, Hugo Daniel Luján3.   

Abstract

The Global Vaccine Action Plan of the World Health Organization (WHO) calls for nonsyringe delivery mechanisms, thermostable vaccines, and new bioprocessing technologies as priority research areas. Here we discuss the use of protozoan surface proteins to develop a safe, stable, and efficient versatile oral vaccine platform.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Keywords:  antimicrobial resistance; antitumor therapy; infectious diseases; oral vaccines; protozoan proteins; virus-like particles

Year:  2019        PMID: 31362858     DOI: 10.1016/j.pt.2019.07.004

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  2 in total

1.  Production of Oral Vaccines Based on Virus-Like Particles Pseudotyped with Protozoan-Surface Proteins.

Authors:  Lucía Lara Rupil; Marianela Del Carmen Serradell; Hugo Daniel Luján
Journal:  Methods Mol Biol       Date:  2022

2.  A Thermostable Oral SARS-CoV-2 Vaccine Induces Mucosal and Protective Immunity.

Authors:  Bertrand Bellier; Alicia Saura; Lucas A Luján; Cecilia R Molina; Hugo D Luján; David Klatzmann
Journal:  Front Immunol       Date:  2022-02-25       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.